FDA Announces Collaborative Review of Scientific Evidence to Support Associations Between Genetic Information and Specific Medications

February 20, 2020 FDA

FDA is providing its view of the state of the current science in pharmacogenetics. FDA’s new web-based resource describes some of the gene-drug interactions for which it believes there is sufficient scientific evidence to support associations between certain genetic variants & specific medications.

Previous Article
FDA Works to Ensure Smooth Regulatory Transition of Insulin and Other Biological Products
FDA Works to Ensure Smooth Regulatory Transition of Insulin and Other Biological Products

Today, the U.S. Food and Drug Administration took additional steps to ensure a smooth regulatory transition...

Next Article
Colorado unapproved drug and dietary supplement makers ordered to cease operations for federal violations
Colorado unapproved drug and dietary supplement makers ordered to cease operations for federal violations

Yesterday, U.S. District Judge Marcia S. Krieger for the U.S. District Court for Colorado entered a consent...